- $1.25bn
- $1.18bn
- $412.98m
- 73
- 39
- 51
- 54
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 20-F/A | 20-F | 20-F |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 263 | 341 | 413 |
Cost of Revenue | ||||
Gross Profit | — | -213 | 2.86 | 69 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 0.727 | 836 | 524 | 487 |
Operating Profit | -0.727 | -573 | -183 | -74.2 |
Total Net Non Operating Interest Income / Expense | ||||
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.628 | -604 | -180 | -80.2 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.628 | -593 | -182 | -85.5 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.628 | -593 | -182 | -85.5 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.628 | -604 | -182 | -85.5 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.018 | -3.95 | -0.794 | -0.314 |